Inlyta
$5,083.08
1MG TAB 180
... people are viewing this right now
Axitinib is a small molecule tyrosine kinase inhibitor developed by Pfizer. It has been shown to significantly inhibit growth of breast cancer in animal models and has shown partial responses in clinical trials with renal cell carcinoma and several other tumour types.
Reviews
There are no reviews yet.